Cara Therapeutics (NQ: CARA )

18.11 USD +0.02 (+0.11%)

Official Closing Price Updated: 5:51 PM EST, Mar 8, 2021 Add to My Watchlist

Price and Volume

Volume	474,200
Open	18.92
Bid (Size)	16.89 (3)
Ask (Size)	18.68 (1)
Prev. Close	18.09
Today's Range	18.09 - 18.95
52wk Range	8.880 - 22.60
Shares Outstanding	33,874,770
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Cara Therapeutics and Vifor Pharma announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

March 08, 2021

Cara Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results

February 25, 2021

Performance

YTD	+20.17%	+20.17%
1 Month	-6.94%	-6.94%
3 Month	+20.73%	+20.73%
6 Month	+17.07%	+17.07%
1 Year	+31.14%	+31.14%

More News

Vifor Pharma and Cara Therapeutics announce U.S. FDA acceptance and Priority Review of NDA for KORSUVA™* injection in hemodialysis patients with moderate-to-severe pruritus

March 08, 2021

Cara Therapeutics to Announce Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021

February 18, 2021

Cara Therapeutics/Vifor Pharma's Korsuva US Application In Pruritus Accepted For Review

March 08, 2021

Cara Initiates Phase 2 Trial of Oral KORSUVA™ for the Treatment of Pruritus in Patients with Notalgia Paresthetica

January 11, 2021

First Week of April 16th Options Trading For Cara Therapeutics

February 24, 2021

Preview: Cara Therapeutics's Earnings

February 24, 2021

Notable Tuesday Option Activity: UNH, CARA, IIPR

February 23, 2021

Cara Therapeutics Inc (CARA) Q4 2020 Earnings Call Transcript

February 26, 2021

Implied XPH Analyst Target Price: $68

February 17, 2021

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.